212 related articles for article (PubMed ID: 18483390)
1. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.
Lanuti M; Liu G; Goodwin JM; Zhai R; Fuchs BC; Asomaning K; Su L; Nishioka NS; Tanabe KK; Christiani DC
Clin Cancer Res; 2008 May; 14(10):3216-22. PubMed ID: 18483390
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk.
Cheung WY; Zhai R; Kulke MH; Heist RS; Asomaning K; Ma C; Wang Z; Su L; Lanuti M; Tanabe KK; Christiani DC; Liu G
Carcinogenesis; 2009 Aug; 30(8):1363-7. PubMed ID: 19520791
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
[TBL] [Abstract][Full Text] [Related]
4. Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study.
Deissova T; Cvanova M; Kala Z; Jiraskova Zakostelska Z; Dolina J; Kunovsky L; Kroupa R; Pavlovsky Z; Lipovy B; Danek Z; Izakovicova Holla L; Urban O; Navratil V; Lischke R; Harustiak T; Grolich T; Prochazka V; Slaby O; Borilova Linhartova P
Dis Markers; 2022; 2022():8790748. PubMed ID: 36092955
[TBL] [Abstract][Full Text] [Related]
5. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma.
Cheung WY; Zhai R; Bradbury P; Hopkins J; Kulke MH; Heist RS; Asomaning K; Ma C; Xu W; Wang Z; Hooshmand S; Su L; Christiani DC; Liu G
Int J Cancer; 2012 Dec; 131(11):2478-86. PubMed ID: 22422400
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
8. Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma.
Menke V; Pot RG; Moons LM; van Zoest KP; Hansen B; van Dekken H; Siersema PD; Kusters JG; Kuipers EJ
J Hum Genet; 2012 Jan; 57(1):26-32. PubMed ID: 22129558
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
[TBL] [Abstract][Full Text] [Related]
10. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.
Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698
[TBL] [Abstract][Full Text] [Related]
11. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
12. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
[TBL] [Abstract][Full Text] [Related]
13. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
14. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
[TBL] [Abstract][Full Text] [Related]
15. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
[TBL] [Abstract][Full Text] [Related]
16. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma.
Menke V; Van Zoest KP; Moons LM; Pot RG; Siersema PD; Kuipers EJ; Kusters JG
Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106
[TBL] [Abstract][Full Text] [Related]
17. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
18. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
[TBL] [Abstract][Full Text] [Related]
19. The Y-chromosome F haplogroup contributes to the development of Barrett's esophagus-associated esophageal adenocarcinoma in a white male population.
Westra WM; Rygiel AM; Mostafavi N; de Wit GMJ; Roes AL; Moons LMG; Peppelenbosch MP; Ouburg S; Morré SA; Jacobs M; Siersema PD; Repping S; Wang KK; Krishnadath KK
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32129453
[TBL] [Abstract][Full Text] [Related]
20. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett's esophagus.
Izakovicova Holla L; Borilova Linhartova P; Hrdlickova B; Marek F; Dolina J; Rihak V; Kala Z
Hum Immunol; 2013 Sep; 74(9):1161-9. PubMed ID: 23806268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]